Deal Announcement

goetzpartners advised Nord Holding

goetzpartners successfully advised Nord Holding on the acquisition financing for the acquisition of hg medical group

Sell-Side Advisory
Debt Advisory
Healthcare and Life Sciences
Transaction
September 2020
Icon: flag-DEIcon: flag-DE

goetzpartners advised

Nord Holding on the

Acquisition Financing

for the acquisition of hg medical group

value not disclosed

Our debt advisory mandate comprised the successful and comprehensive management of a competitive acquisition financing process. We provided key support during the transaction by structuring a demanding and competitive financing solution in a complex cross-border setup with majority of sales being generated in the US. During the transaction we approached relevant banks and debt funds alike and played a vital role in lender education and the compilation of relevant information documents. By coordinating and providing feedback to the respective due diligence providers we ensured tailor-made and bankable due diligence reports could be provided to the interested financing parties. Within a competitive term sheet process we secured optimal financing terms for hg medical and Nord Holding, ensuring that the established financing structure provides maximum flexibility to support further organic and inorganic growth of the group. With our successful management of the financing process we provided key support to Nord Holding to provide the best purchase offer, sign the SPA and win the acquisition of hg medical group during a short exclusivity period within a competitive M&A process organized by Quarton International.

About Nord Holding
Nord Holding is a successful mid-cap private equity asset manager from Hanover founded in 1969 with focus on direct and fund investments and over €2.5bn assets under management.

About hg medical
hg medical is a vertically integrated contract manufacturer for orthopedic implants. The customers are mainly large medical technology companies that hg medical supports in the technical implementation of product innovations, development services and individual customer solutions. The focus is on technically demanding and complex implants.


Transaction team:

 

Philipp Widmaier
Managing Director

Marius Wolter
Associate

Extended transaction team:

Maximilian Zeiler
Associate Director

Weitere TransaktionenDas könnte Sie auch interessieren...

Dezember 2022
Icon: flag-CHIcon: flag-DE

goetzpartners advised

Deutsche Invest Capital Solutions with a

Commercial Due Diligence
Acquisition Financing

on the acquisition of GLOBOGATE concept AG

value not disclosed

Januar 2021
Icon: flag-DEIcon: flag-DE

goetzpartners advised

Afinum on the

Acquisition Financing

for the acquisition of SanderStrothmann Group

value not disclosed